Johnson & Johnson to Participate in Barclays Global Healthcare Conference

On February 26, 2020 Johnson & Johnson (NYSE: JNJ) reported that it will participate in the Barclays Global Healthcare Conference on Wednesday, March 11th, at the Loews Miami Beach Hotel, Miami Beach, FL (Press release, Johnson & Johnson, FEB 26, 2020, View Source;johnson-to-participate-in-barclays-global-healthcare-conference-301011995.html [SID1234554833]). Ciro Romer, Company Group Chairman, Medical Devices North America will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time) .

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately two hours after the live webcast.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!